Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      • Home
      • Meghna A Singhania

      Articles By : Meghna A Singhania

      20 percent of Indian pharma sales to be disrupted by Jan Aushadhi Scheme: Edelweiss Report

      20 percent of Indian pharma sales to be disrupted by Jan Aushadhi Scheme: Edelweiss Report

      Meghna A Singhania16 March 2019 1:19 PM IST
      The report by Edelweiss expects that around Rs 6,000 crore of the Bureau of Pharma PSUs of India (BPPI) drugs could adversely impact around Rs...
      Delhi: CDSCO raids 45 units illegally making Orthopedic medical devices

      Delhi: CDSCO raids 45 units illegally making Orthopedic medical devices

      Meghna A Singhania14 March 2019 5:29 PM IST
      Central Drugs Standard Control Organization(CDSCO) has conducted raids at 25 factories in Delhi alone. Whereas eight facilities were inspected in...
      NPPA revises MRP of another 463 anti cancer medicines; Check Details

      NPPA revises MRP of another 463 anti cancer medicines; Check Details

      Meghna A Singhania13 March 2019 4:39 PM IST
      NEW DELHI: Through a recent official release, National Pharmaceutical Pricing Authority (NPPA) has informed about the revision in the maximum retail...
      Central Drug Regulator directs states, UTs to ban sale, manufacture, ad of e cigarettes

      Central Drug Regulator directs states, UTs to ban sale, manufacture, ad of e cigarettes

      Meghna A Singhania13 March 2019 9:30 AM IST
      In August last year, the Health Ministry issued an advisory to all states and UTs to stop the manufacture, sale and import of ENDS after the Delhi HC...
      CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

      CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

      Meghna A Singhania12 March 2019 2:03 PM IST
      Hydroquinone is also added to the CDSCO OTC ban list after several cases have shown that its unchecked sale is leading to adverse effects on skin such...
      Landmark: JnJ told to pay Rs 74.5 lakh to patient by CDSCO

      Landmark: JnJ told to pay Rs 74.5 lakh to patient by CDSCO

      Meghna A Singhania11 March 2019 12:19 PM IST
      This is the first case where M/s Johnson and Johnson has been directed to pay compensation for its faulty ASR hip implants manufactured and imported...
      NPPA slashes price of 390 cancer medicine by up to 87 per cent; Check out full Details

      NPPA slashes price of 390 cancer medicine by up to 87 per cent; Check out full Details

      Meghna A Singhania9 March 2019 1:39 PM IST
      The NPPA move is expected to benefit 22 lakh cancer patients in the country and would result in annual savings of around Rs 800 crore to the...
      New law for labelling Drugs, Fixed Dose Combinations: Govt issues Gazette

      New law for labelling Drugs, Fixed Dose Combinations: Govt issues Gazette

      Meghna A Singhania8 March 2019 3:12 PM IST
      Objections and suggestions, if any, may be addressed to the Under Secretary (Drugs), Ministry of Health and Family Welfare, Government of India, Room...
      Coming Soon: Pharmacists may be allowed to substitute branded drugs with generics

      Coming Soon: Pharmacists may be allowed to substitute branded drugs with generics

      Meghna A Singhania7 March 2019 11:55 AM IST
      The code of ethics issued by MCI calls for doctors to prescribe drugs by their generic name, however, due to lack of substitution law, pharmacists in...
      Setback to JnJ baby Powder: DCGI issues show cause notice for violating drug law

      Setback to JnJ baby Powder: DCGI issues show cause notice for violating drug law

      Meghna A Singhania6 March 2019 5:22 PM IST
      The notice issued to J&J quotes, “Publication of such advertisement has the potential to mislead the general public which is against the public...
      Setback to Meril Lifesciences MeRess100: NPPA refuses to give relief of price cap exemption for the biodegradable stent

      Setback to Meril Lifesciences MeRess100: NPPA refuses to give relief of price cap exemption for the biodegradable stent

      Meghna A Singhania5 March 2019 5:01 PM IST
      New Delhi: In a major setback to Meril Lifesciences, the drug price regulator National Pharmaceutical Pricing Authority(NPPA) has refused to give it...
      Unfair Practices: GMC Chandigarh housed Chemist Shop slapped Rs 25,000 FINE for Overcharging Patients

      Unfair Practices: GMC Chandigarh housed Chemist Shop slapped Rs 25,000 FINE for Overcharging Patients

      Meghna A Singhania4 March 2019 5:22 PM IST
      It was contended that GMCH is allegedly the authority controlling the misdeeds of the chemist shop as it is their licensee within the complex and...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok